Company / Cost of Revenue
ClearPoint Neuro, Inc. Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$14.3M
FY2025
5-year range
$5.2M / $14.3M
FY2021-FY2025
Trend
+38.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cost of Revenue has fluctuated over the past 10 years, ranging from $2M in FY2018 to $14M in FY2025.
Based on SEC 10-K filings.
$14M in FY2025 with a 5-year CAGR of +30.9%.
Increased from $10M to $14M over the past 2 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +26.7%
- 5-Year CAGR
- +30.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +30.9%, indicating consistent growth.
- In FY2025, cost of revenue increased 38.1% year-over-year.
- Lowest cost of revenue in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -1.71 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $14.3M | +38.1% |
| FY2024 | $10.3M | +0.0% |
| FY2023 | $10.3M | +47.3% |
| FY2022 | $7.0M | +35.6% |
| FY2021 | $5.2M | +39.6% |
| FY2020 | $3.7M | -5.9% |
| FY2019 | $3.9M | +62.0% |
| FY2018 | $2.4M | -16.1% |
| FY2017 | $2.9M | +9.7% |
| FY2016 | $2.6M | +33.0% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026